Brain metastases often occur as a result of advanced cancer and, despite medical innovations, are still associated with a poor prognosis. Now, an international expert committee has taken an important ...

Brain metastases often occur as a result of advanced cancer, and despite medical innovations, are still associated with a ...

During a live event, Ahmad Tarhini, MD, PhD, discussed the RELATIVITY-047 trial of nivolumab/relatlimab vs nivolumab alone in ...

The Congress of Neurological Surgeons (CNS) has updated its guidelines on using emerging therapies to treat metastatic brain ...

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Medulloblastoma is one of the most common malignant tumors of the central nervous system (CNS) in children and adolescents.

Results from phase 2 trials appear to support the use of chemotherapy-free regimens in patients with osimertinib-resistant ...

New research suggests that a ctDNA assay can detect colorectal cancer recurrence months before it is detected via imaging.

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Panelists discuss how the 5-year CROWN trial data for lorlatinib have shaped the treatment paradigm for ALK+ metastatic ...

In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor ...